New, Study

New Study Positions Nevisense's EIS as a valuable and sensitive tool for assessing skin barrier impairment

Veröffentlicht: 17.03.2026 um 19:18 Uhr, prnewswire.co.uk

SciBase Sweden

en | boerse | 68728754 |